Pharmaron Beijing Co Ltd
SZSE:300759

Watchlist Manager
Pharmaron Beijing Co Ltd Logo
Pharmaron Beijing Co Ltd
SZSE:300759
Watchlist
Price: 30.55 CNY -1.23% Market Closed
Market Cap: 45.4B CNY
Have any thoughts about
Pharmaron Beijing Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Pharmaron Beijing Co Ltd stock under the Base Case scenario is 36.31 CNY. Compared to the current market price of 30.55 CNY, Pharmaron Beijing Co Ltd is Undervalued by 16%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
36.31 CNY
Undervaluation 16%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Pharmaron Beijing Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Pharmaron Beijing Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Pharmaron Beijing Co Ltd?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Life Sciences Tools & Services Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Pharmaron Beijing Co Ltd

Provide an overview of the primary business activities
of Pharmaron Beijing Co Ltd.

What unique competitive advantages
does Pharmaron Beijing Co Ltd hold over its rivals?

What risks and challenges
does Pharmaron Beijing Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Pharmaron Beijing Co Ltd.

Provide P/S
for Pharmaron Beijing Co Ltd.

Provide P/E
for Pharmaron Beijing Co Ltd.

Provide P/OCF
for Pharmaron Beijing Co Ltd.

Provide P/FCFE
for Pharmaron Beijing Co Ltd.

Provide P/B
for Pharmaron Beijing Co Ltd.

Provide EV/S
for Pharmaron Beijing Co Ltd.

Provide EV/GP
for Pharmaron Beijing Co Ltd.

Provide EV/EBITDA
for Pharmaron Beijing Co Ltd.

Provide EV/EBIT
for Pharmaron Beijing Co Ltd.

Provide EV/OCF
for Pharmaron Beijing Co Ltd.

Provide EV/FCFF
for Pharmaron Beijing Co Ltd.

Provide EV/IC
for Pharmaron Beijing Co Ltd.

Show me price targets
for Pharmaron Beijing Co Ltd made by professional analysts.

What are the Revenue projections
for Pharmaron Beijing Co Ltd?

How accurate were the past Revenue estimates
for Pharmaron Beijing Co Ltd?

What are the Net Income projections
for Pharmaron Beijing Co Ltd?

How accurate were the past Net Income estimates
for Pharmaron Beijing Co Ltd?

What are the EPS projections
for Pharmaron Beijing Co Ltd?

How accurate were the past EPS estimates
for Pharmaron Beijing Co Ltd?

What are the EBIT projections
for Pharmaron Beijing Co Ltd?

How accurate were the past EBIT estimates
for Pharmaron Beijing Co Ltd?

Compare the revenue forecasts
for Pharmaron Beijing Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Pharmaron Beijing Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Pharmaron Beijing Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Pharmaron Beijing Co Ltd compared to its peers.

Compare the P/E ratios
of Pharmaron Beijing Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Pharmaron Beijing Co Ltd with its peers.

Analyze the financial leverage
of Pharmaron Beijing Co Ltd compared to its main competitors.

Show all profitability ratios
for Pharmaron Beijing Co Ltd.

Provide ROE
for Pharmaron Beijing Co Ltd.

Provide ROA
for Pharmaron Beijing Co Ltd.

Provide ROIC
for Pharmaron Beijing Co Ltd.

Provide ROCE
for Pharmaron Beijing Co Ltd.

Provide Gross Margin
for Pharmaron Beijing Co Ltd.

Provide Operating Margin
for Pharmaron Beijing Co Ltd.

Provide Net Margin
for Pharmaron Beijing Co Ltd.

Provide FCF Margin
for Pharmaron Beijing Co Ltd.

Show all solvency ratios
for Pharmaron Beijing Co Ltd.

Provide D/E Ratio
for Pharmaron Beijing Co Ltd.

Provide D/A Ratio
for Pharmaron Beijing Co Ltd.

Provide Interest Coverage Ratio
for Pharmaron Beijing Co Ltd.

Provide Altman Z-Score Ratio
for Pharmaron Beijing Co Ltd.

Provide Quick Ratio
for Pharmaron Beijing Co Ltd.

Provide Current Ratio
for Pharmaron Beijing Co Ltd.

Provide Cash Ratio
for Pharmaron Beijing Co Ltd.

What is the historical Revenue growth
over the last 5 years for Pharmaron Beijing Co Ltd?

What is the historical Net Income growth
over the last 5 years for Pharmaron Beijing Co Ltd?

What is the current Free Cash Flow
of Pharmaron Beijing Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Pharmaron Beijing Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Pharmaron Beijing Co Ltd

Current Assets 7.1B
Cash & Short-Term Investments 2.7B
Receivables 2.9B
Other Current Assets 1.5B
Non-Current Assets 15.9B
Long-Term Investments 968m
PP&E 10.4B
Intangibles 3.6B
Other Non-Current Assets 953.7m
Current Liabilities 3.9B
Accounts Payable 503m
Accrued Liabilities 732.6m
Short-Term Debt 556.1m
Other Current Liabilities 2.1B
Non-Current Liabilities 6.1B
Long-Term Debt 4.8B
Other Non-Current Liabilities 1.3B
Efficiency

Earnings Waterfall
Pharmaron Beijing Co Ltd

Revenue
11.5B CNY
Cost of Revenue
-7.7B CNY
Gross Profit
3.8B CNY
Operating Expenses
-2.3B CNY
Operating Income
1.6B CNY
Other Expenses
355.7m CNY
Net Income
1.9B CNY

Free Cash Flow Analysis
Pharmaron Beijing Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Pharmaron Beijing Co Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Positive 3-Year Average ROE
Positive Revenue Growth Forecast
55/100
Profitability
Score

Pharmaron Beijing Co Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Pharmaron Beijing Co Ltd's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
60/100
Solvency
Score

Pharmaron Beijing Co Ltd's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Pharmaron Beijing Co Ltd

Wall Street analysts forecast Pharmaron Beijing Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Pharmaron Beijing Co Ltd is 24.44 CNY with a low forecast of 8.28 CNY and a high forecast of 45.68 CNY.

Lowest
Price Target
8.28 CNY
73% Downside
Average
Price Target
24.44 CNY
20% Downside
Highest
Price Target
45.68 CNY
50% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Pharmaron Beijing Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Pharmaron Beijing Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Pharmaron Beijing Co Ltd Logo
Pharmaron Beijing Co Ltd

Country

China

Industry

Life Sciences Tools & Services

Market Cap

45.4B CNY

Dividend Yield

0.65%

Description

Pharmaron Beijing Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Beijing, Beijing and currently employs 14,923 full-time employees. The company went IPO on 2019-01-28. Pharmaron Beijing Co., Ltd. is a China-based company that provides research and manufacturing services throughout the discovery, development and manufacturing spectrum for small molecule drugs, cell therapies and gene therapies as well as providing testing services for medical devices and clinic research. The firm has four segments. The Laboratory Services segment includes laboratory chemistry, drug metabolism and pharmacokinetics/absorption, distribution, metabolism and excretion, biology, safety assessment and discovery of biologics services. The Clinical Development Services segment includes clinical research, site management organization, regulatory bioanalysis and radiolabelled sciences service. The Chemistry, Manufactory and Control Services segment includes process development and manufacturing, material science/pre-formulation, formulation development and manufacturing and analytical development and commercial manufacturing services. The firm also operates Others segment.

Contact

BEIJING
Beijing
No. 6 Taihe Road, Beijing Economic and Technological Development Zone
+861057330087.0
www.pharmaron.cn

IPO

2019-01-28

Employees

14 923

Officers

Chairman & CEO
Dr. Boliang Lou Ph.D.
Co-Founder, President, COO & Executive Director
Mr. Xiaoqiang Lou EMBA
Executive VP & Executive Director
Ms. Bei Zheng M.A, M.A.
CFO & Secretary of the Board
Mr. Shing Chung Li C.F.A., CPA
Chief Scientific Officer & Deputy Manager
Dr. Hua Yang Ph.D.
Senior VP & Global Head of Business Development of Small Molecules
Dr. Connie Sun Ph.D.
Show More
Senior Vice President of Human Resources
Ms. Celina Zhong M.B.A., MBA
Chief Business Officer
Ms. Katherine Lee M.B.A., MBA
Senior Vice President of UK Operations
Mr. Stephen Lewinton
Senior Vice President of In Vivo Pharmacology
Dr. Jingqi Huang
Show Less

See Also

Discover More
What is the Intrinsic Value of one Pharmaron Beijing Co Ltd stock?

The intrinsic value of one Pharmaron Beijing Co Ltd stock under the Base Case scenario is 36.31 CNY.

Is Pharmaron Beijing Co Ltd stock undervalued or overvalued?

Compared to the current market price of 30.55 CNY, Pharmaron Beijing Co Ltd is Undervalued by 16%.

Back to Top